NEW YORK, March 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Allianz SE (“Allianz” or the “Company”) (OTCMKTS: ALIZY). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
Month: March 2023
NEW YORK, March 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Medical Properties Trust, Inc. (“MPT” or the “Company”) (NYSE: MPW). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, March 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, March 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Kornit Digital Ltd. (“Kornit” or the “Company”) (NASDAQ: KRNT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, March 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Robinhood Markets, Inc. (“Robinhood” or the “Company”) (NASDAQ: HOOD). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
DUBLIN, March 3, 2023 /PRNewswire/ — The “MENA-3 Games Market Report” report has been added to ResearchAndMarkets.com’s offering. What You’ll Learn from this Report: This report covers the MENA (Middle East North Africa) region. The MENA games market has quickly emerged as a key growth…
NEW YORK, March 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of PLDT Inc. (“PLDT” or the “Company”) (NYSE: PHI). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation…
NEW YORK, March 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Fulcrum Therapeutics, Inc. (“Fulcrum” or the “Company”) (NASDAQ: FULC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980….
NEW YORK, March 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Southwest Airlines Co. (“Southwest” or the “Company”) (NYSE: LUV). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
DUBLIN, March 3, 2023 /PRNewswire/ — The “CX for the 21st Century” report has been added to ResearchAndMarkets.com’s offering. The publisher’s special edition Report, CX for the 21st Century, analyzes the current state of most customer-facing contact centers, outlines a strategy and…